***Live: Tuesday, February 23, 2021 at 2pm EST | 1pm CST | 11am PST*** Are you involved in the design of clinical trials to measure the role of the gut microbiome in cognitive health disorders such as stress, mood, anxiety, depression, or mild cognitive impairment? Vedic Lifesciences is delighted to invite you to a live webcast led by clinical neuroscientist and nutrition researcher Miguel Toribio-Mateas and Shalini Srivastava, MD, who will share their insights on methodology, markers, and practicalities for microbiome-gut-brain-axis clinical trials. *** On demand until Feb. 23, 2022***
The gut-brain axis is a popular topic these days—and the subject of numerous webcasts. But one topic not often discussed is how clinical trials are being designed on the gut-brain axis.
Nutritional studies on the gut microbiome are increasingly of interest, particularly as they relate to mood disorders such as anxiety and depression as well as cognitive performance measures. In this webcast, we examine how gut-brain-axis clinical trials are being designed. Researchers interested in investigating the role of the gut microbiome in cognitive health disorders such as stress, mood, anxiety, depression, or cognitive performance measures like memory, attention, focus and alertness, you won’t want to miss this webcast.
Key Learning Objectives:
Speaker: Miguel Toribio-Mateas, MSc, DProf (c), Clinical Neuroscientist and Nutrition Researcher, Atlas Biomed
Shalini Srivastava, MD, Director Clinical Development, Vedic Lifesciences
Time and Date: Tuesday, February 23, 2021 at 2pm EST | 1pm CST | 11am PST
On Demand Until Feb. 23, 2022.
Sponsors: Vedic Lifesciences